Literature DB >> 24944923

Link between hypothyroidism and small intestinal bacterial overgrowth.

Anant D Patil1.   

Abstract

Altered gastrointestinal (GI) motility is seen in many pathological conditions. Reduced motility is one of the risk factors for development of a small intestinal bacterial overgrowth (SIBO). Hypothyroidism is associated with altered GI motility. The aim of this article was to study the link between hypothyroidism, altered GI motility and development of SIBO. Published literature was reviewed to study the association of altered GI motility, SIBO and hypothyroidism. Altered GI motility leads to SIBO. SIBO is common in patients with hypothyroidism. Patients with chronic GI symptoms in hypothyroidism should be evaluated for the possibility of SIBO. Both antibiotics and probiotics have been studied and found to be effective in management of SIBO.

Entities:  

Keywords:  Breath test; hypothyroidism; small intestinal bacterial overgrowth

Year:  2014        PMID: 24944923      PMCID: PMC4056127          DOI: 10.4103/2230-8210.131155

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


  15 in total

1.  Small intestinal bacterial overgrowth: diagnosis and treatment.

Authors:  Antonio Gasbarrini; Ernesto Cristiano Lauritano; Maurizio Gabrielli; Emidio Scarpellini; Andrea Lupascu; Veronica Ojetti; Giovanni Gasbarrini
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

2.  Association between hypothyroidism and small intestinal bacterial overgrowth.

Authors:  Ernesto Cristiano Lauritano; Anna Lisa Bilotta; Maurizio Gabrielli; Emidio Scarpellini; Andrea Lupascu; Antonio Laginestra; Marialuisa Novi; Sandra Sottili; Michele Serricchio; Giovanni Cammarota; Giovanni Gasbarrini; Alfredo Pontecorvi; Antonio Gasbarrini
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

3.  Bacillus clausii as a treatment of small intestinal bacterial overgrowth.

Authors:  Maurizio Gabrielli; Ernesto Cristiano Lauritano; Emidio Scarpellini; Andrea Lupascu; Veronica Ojetti; Giovanni Gasbarrini; Nicolò Gentiloni Silveri; Antonio Gasbarrini
Journal:  Am J Gastroenterol       Date:  2009-04-07       Impact factor: 10.864

4.  Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity.

Authors:  Paul J Lappinga; Susan C Abraham; Joseph A Murray; Emily A Vetter; Robin Patel; Tsung-Teh Wu
Journal:  Arch Pathol Lab Med       Date:  2010-02       Impact factor: 5.534

5.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

6.  The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.

Authors:  G Vantrappen; J Janssens; J Hellemans; Y Ghoos
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Does hypothyroidism affect gastrointestinal motility?

Authors:  Olga Yaylali; Suna Kirac; Mustafa Yilmaz; Fulya Akin; Dogangun Yuksel; Nese Demirkan; Beyza Akdag
Journal:  Gastroenterol Res Pract       Date:  2010-03-07       Impact factor: 2.260

8.  Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Authors:  Sergio Peralta; Claudia Cottone; Tiziana Doveri; Piero Luigi Almasio; Antonio Craxi
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

9.  Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.

Authors:  L Cuoco; M Salvagnini
Journal:  Minerva Gastroenterol Dietol       Date:  2006-03

10.  Diarrhea in hypothyroidism: bacterial overgrowth as a possible etiology.

Authors:  E Goldin; D Wengrower
Journal:  J Clin Gastroenterol       Date:  1990-02       Impact factor: 3.062

View more
  4 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Routine Treatment-Resistant Clostridium difficile Infection during Recovery from Myxedema.

Authors:  Jan K Adamski; Björn B Jäschke; Raija S Uusitalo-Seppälä; Kalle V J Moilanen; Antti V Pehkonen; Wojciech Weigl
Journal:  Case Rep Gastroenterol       Date:  2017-11-29

3.  Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis.

Authors:  Leonardo César de Freitas Cayres; Larissa Vedovato Vilela de Salis; Guilherme Siqueira Pardo Rodrigues; André van Helvoort Lengert; Ana Paula Custódio Biondi; Larissa Donadel Barreto Sargentini; João Luiz Brisotti; Eleni Gomes; Gislane Lelis Vilela de Oliveira
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

4.  Levothyroxine Sodium Oral Solution Normalizes Thyroid Function in a Patient with Hashimoto's Disease, Gastritis, Diabetic Gastroparesis, and Small Intestinal Bacterial Overgrowth (SIBO).

Authors:  Brittany Bohinc Henderson
Journal:  Int Med Case Rep J       Date:  2021-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.